rs1557043622
|
|
A |
0.700 |
GeneticVariation |
CLINVAR |
SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals.
|
30817854 |
2019 |
rs757075712
|
|
T |
0.700 |
GeneticVariation |
CLINVAR |
|
|
|
rs211037
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Multivariate analysis indicated that hypoalbuminemia (<3 g/dL), long-acting (t 1/2 > 12-h), high-dosage (>1.5 defined daily dose equivalents) and long-duration (>2-months) BZD use, carrier of variant genotypes (AG + GG) of GABRA 1 (rs2290732) and having the wild genotype (TT) of GABRG 2 (rs211037) were significant predictors of the development of BZD-associated HE in cirrhotic patients.
|
24482035 |
2014 |
rs2290732
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Multivariate analysis indicated that hypoalbuminemia (<3 g/dL), long-acting (t 1/2 > 12-h), high-dosage (>1.5 defined daily dose equivalents) and long-duration (>2-months) BZD use, carrier of variant genotypes (AG + GG) of GABRA 1 (rs2290732) and having the wild genotype (TT) of GABRG 2 (rs211037) were significant predictors of the development of BZD-associated HE in cirrhotic patients.
|
24482035 |
2014 |
rs200482683
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The second, a 31-year-old woman-compound heterozygous for p.V290M and p.R138Q-was first detected with hypoalbuminemia (<30 g/l) and edema at the age of 24.3 and 27.5 years, respectively.
|
23242530 |
2013 |
rs74315342
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The second, a 31-year-old woman-compound heterozygous for p.V290M and p.R138Q-was first detected with hypoalbuminemia (<30 g/l) and edema at the age of 24.3 and 27.5 years, respectively.
|
23242530 |
2013 |
rs767419411
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The second, a 31-year-old woman-compound heterozygous for p.V290M and p.R138Q-was first detected with hypoalbuminemia (<30 g/l) and edema at the age of 24.3 and 27.5 years, respectively.
|
23242530 |
2013 |
rs121908131
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In conclusion, patients with early onset ataxia with ocular motor apraxia and hypoalbuminaemia homozygous for the c.689_690insT mutation show a more severe phenotype than those with a p.Pro206Leu or p.Val263Gly mutation.
|
21486904 |
2011 |
rs121908132
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In conclusion, patients with early onset ataxia with ocular motor apraxia and hypoalbuminaemia homozygous for the c.689_690insT mutation show a more severe phenotype than those with a p.Pro206Leu or p.Val263Gly mutation.
|
21486904 |
2011 |